Details for: HNRNPA3

Gene ID: 220988

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: HNRNPA3

Ensembl ID: ENSG00000170144

Description: heterogeneous nuclear ribonucleoprotein A3

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • hematopoietic stem cell CL0000037
    CSI 119.2
    rCSI 79.23%
    PRS 3.7
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 98.43
    rCSI 88.89%
    PRS 2.74
  • common myeloid progenitor CL0000049
    CSI 97.55
    rCSI 78.87%
    PRS 3.05
  • granulocyte monocyte progenitor cell CL0000557
    CSI 95.82
    rCSI 82.96%
    PRS 3.48
  • plasmablast CL0000980
    CSI 91.87
    rCSI 72.27%
    PRS 3.7
  • keratinocyte CL0000312
    CSI 89.93
    rCSI 75.38%
    PRS 3.75
  • pro-B cell CL0000826
    CSI 88.47
    rCSI 73.27%
    PRS 3.11
  • fallopian tube secretory epithelial cell CL4030006
    CSI 84.93
    rCSI 81.76%
    PRS 3.25
  • epithelial cell of lung CL0000082
    CSI 83.56
    rCSI 69.27%
    PRS 2.92
  • early lymphoid progenitor CL0000936
    CSI 81.88
    rCSI 71.91%
    PRS 3.48
  • ciliated epithelial cell CL0000067
    CSI 81.71
    rCSI 71.85%
    PRS 2.26
  • stem cell CL0000034
    CSI 76.8
    rCSI 74.06%
    PRS 1.33
  • plasmacytoid dendritic cell, human CL0001058
    CSI 76.33
    rCSI 53.29%
    PRS 3.28
  • neural crest cell CL0011012
    CSI 75.91
    rCSI 60%
    PRS 2.16
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 71.38
    rCSI 47.57%
    PRS 8.84
  • common dendritic progenitor CL0001029
    CSI 71.32
    rCSI 89.5%
    PRS 3.94
  • group 3 innate lymphoid cell CL0001071
    CSI 69.48
    rCSI 52.2%
    PRS 3.2
  • intestinal epithelial cell CL0002563
    CSI 68.34
    rCSI 71.43%
    PRS 3.32
  • transit amplifying cell of colon CL0009011
    CSI 68.16
    rCSI 80.05%
    PRS 3.81
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 67.82
    rCSI 52.25%
    PRS 2.8
  • fraction A pre-pro B cell CL0002045
    CSI 63.83
    rCSI 73.06%
    PRS 6.49
  • enteric smooth muscle cell CL0002504
    CSI 61.49
    rCSI 87.75%
    PRS 3.56
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 59.97
    rCSI 44.97%
    PRS 9.45
  • multi-ciliated epithelial cell CL0005012
    CSI 59.77
    rCSI 59.65%
    PRS 2.63
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 59.4
    rCSI 68.6%
    PRS 2.85
  • colon epithelial cell CL0011108
    CSI 58.01
    rCSI 60.76%
    PRS 2.91
  • common lymphoid progenitor CL0000051
    CSI 57.36
    rCSI 76.65%
    PRS 5.96
  • lung ciliated cell CL1000271
    CSI 56.78
    rCSI 65.65%
    PRS 2.26
  • intestine goblet cell CL0019031
    CSI 55.17
    rCSI 48.97%
    PRS 3.12
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 54.14
    rCSI 55.17%
    PRS 4.53
  • double negative thymocyte CL0002489
    CSI 53.43
    rCSI 37.15%
    PRS 3.65
  • pancreatic A cell CL0000171
    CSI 52.94
    rCSI 55.46%
    PRS 3.36
  • placental villous trophoblast CL2000060
    CSI 52.74
    rCSI 81.49%
    PRS 2.93
  • promyelocyte CL0000836
    CSI 52.14
    rCSI 75.21%
    PRS 4.32
  • mesodermal cell CL0000222
    CSI 51.54
    rCSI 61.87%
    PRS 3.11
  • mature B cell CL0000785
    CSI 51
    rCSI 44.34%
    PRS 3.83
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 49.15
    rCSI 33.11%
    PRS 3.78
  • transit amplifying cell CL0009010
    CSI 46.16
    rCSI 70.6%
    PRS 5.1
  • precursor B cell CL0000817
    CSI 44.83
    rCSI 39.27%
    PRS 4.2
  • promonocyte CL0000559
    CSI 44.77
    rCSI 76.7%
    PRS 4.16
  • peripheral nervous system neuron CL2000032
    CSI 43.34
    rCSI 59.05%
    PRS 2.82
  • extravillous trophoblast CL0008036
    CSI 43.34
    rCSI 53.61%
    PRS 2.74
  • enteroendocrine cell CL0000164
    CSI 41.04
    rCSI 56.07%
    PRS 3.45
  • goblet cell CL0000160
    CSI 38.82
    rCSI 36.69%
    PRS 3.25
  • mucous neck cell CL0000651
    CSI 38.02
    rCSI 54.8%
    PRS 5.07
  • epithelial cell of lower respiratory tract CL0002632
    CSI 37.72
    rCSI 29.24%
    PRS 2.96
  • M cell of gut CL0000682
    CSI 35.93
    rCSI 38.18%
    PRS 5.59
  • epithelial cell CL0000066
    CSI 35.93
    rCSI 55.21%
    PRS 4.54
  • conventional dendritic cell CL0000990
    CSI 35.67
    rCSI 29.78%
    PRS 10.29
  • pancreatic ductal cell CL0002079
    CSI 33.56
    rCSI 65.28%
    PRS 3.18
  • respiratory suprabasal cell CL4033048
    CSI 33.48
    rCSI 42.94%
    PRS 3.6
  • radial glial cell CL0000681
    CSI 33.35
    rCSI 46.34%
    PRS 3.29
  • myeloid dendritic cell CL0000782
    CSI 33.08
    rCSI 47.92%
    PRS 4.57
  • conjunctival epithelial cell CL1000432
    CSI 32.63
    rCSI 49.83%
    PRS 3.13
  • pancreatic acinar cell CL0002064
    CSI 31.65
    rCSI 42.07%
    PRS 3.42
  • foveolar cell of stomach CL0002179
    CSI 29.77
    rCSI 63.37%
    PRS 5.09
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 29.7
    rCSI 59.2%
    PRS 5.35
  • CD4-positive helper T cell CL0000492
    CSI 29.1
    rCSI 22.01%
    PRS 4.36
  • large pre-B-II cell CL0000957
    CSI 28.81
    rCSI 82.25%
    PRS 5.53
  • plasmacytoid dendritic cell CL0000784
    CSI 28.71
    rCSI 29.08%
    PRS 20.67
  • interstitial cell of Cajal CL0002088
    CSI 28.39
    rCSI 36.14%
    PRS 3.65
  • progenitor cell CL0011026
    CSI 28.25
    rCSI 60.08%
    PRS 6.19
  • microcirculation associated smooth muscle cell CL0008035
    CSI 28.17
    rCSI 81.56%
    PRS 3.54
  • myeloid leukocyte CL0000766
    CSI 27.9
    rCSI 25.74%
    PRS 3.15
  • colon goblet cell CL0009039
    CSI 27.85
    rCSI 66.21%
    PRS 4.77
  • mature T cell CL0002419
    CSI 27.22
    rCSI 21.17%
    PRS 4.51
  • BEST4+ enteroycte CL4030026
    CSI 27.18
    rCSI 33.81%
    PRS 3.32
  • glandular epithelial cell CL0000150
    CSI 27.15
    rCSI 71.48%
    PRS 6.13
  • stromal cell of ovary CL0002132
    CSI 25.73
    rCSI 70.71%
    PRS 5.25
  • hematopoietic precursor cell CL0008001
    CSI 25.72
    rCSI 26.46%
    PRS 5.11
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 25.65
    rCSI 99.85%
    PRS 5.16
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 25.07
    rCSI 60.32%
    PRS 4.92
  • luminal epithelial cell of mammary gland CL0002326
    CSI 24.68
    rCSI 44.84%
    PRS 4.79
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 24.24
    rCSI 29.38%
    PRS 4.84
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 24.24
    rCSI 65.34%
    PRS 4.08
  • small pre-B-II cell CL0000954
    CSI 23.65
    rCSI 22.74%
    PRS 6.81
  • thymocyte CL0000893
    CSI 23.04
    rCSI 81.88%
    PRS 10.31
  • intermediate monocyte CL0002393
    CSI 22.97
    rCSI 34.66%
    PRS 3.05
  • paneth cell of epithelium of small intestine CL1000343
    CSI 22.91
    rCSI 64.21%
    PRS 4.94
  • immature B cell CL0000816
    CSI 22.87
    rCSI 16.99%
    PRS 4.65
  • dendritic cell, human CL0001056
    CSI 22.83
    rCSI 35.06%
    PRS 3.61
  • forebrain radial glial cell CL0013000
    CSI 22.49
    rCSI 72.17%
    PRS 4.78
  • type EC enteroendocrine cell CL0000577
    CSI 22.29
    rCSI 79.14%
    PRS 5.15
  • mammary gland epithelial cell CL0002327
    CSI 21.97
    rCSI 77.09%
    PRS 5.67
  • respiratory hillock cell CL4030023
    CSI 21.44
    rCSI 38.24%
    PRS 5.41
  • germinal center B cell CL0000844
    CSI 21.44
    rCSI 63.93%
    PRS 8.57
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 21.23
    rCSI 12.54%
    PRS 4.35
  • club cell CL0000158
    CSI 21.12
    rCSI 30.93%
    PRS 3.69
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 21
    rCSI 25.36%
    PRS 3.59
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 20.98
    rCSI 26.92%
    PRS 3.11
  • enterocyte CL0000584
    CSI 20.95
    rCSI 33.78%
    PRS 5.07
  • dendritic cell CL0000451
    CSI 20.78
    rCSI 25.61%
    PRS 10.4
  • tendon cell CL0000388
    CSI 20.17
    rCSI 52.41%
    PRS 9.8
  • T-helper 1 cell CL0000545
    CSI 19.8
    rCSI 35.75%
    PRS 9.68
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 19.08
    rCSI 98.51%
    PRS 6.23
  • memory B cell CL0000787
    CSI 19.05
    rCSI 18.81%
    PRS 13.82
  • gamma-delta T cell CL0000798
    CSI 18.78
    rCSI 22.06%
    PRS 31.03
  • respiratory basal cell CL0002633
    CSI 18.7
    rCSI 19.37%
    PRS 3.64
  • mesenchymal cell CL0008019
    CSI 18.63
    rCSI 47.31%
    PRS 3.19
  • enteroendocrine cell of small intestine CL0009006
    CSI 18.36
    rCSI 40.41%
    PRS 4.89
  • squamous epithelial cell CL0000076
    CSI -32.8
    rCSI -77.8%
    PRS 4.2%
  • alpha-beta T cell CL0000789
    CSI -11.5
    rCSI -13.5%
    PRS 5.2%
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI -10.7
    rCSI -8.6%
    PRS 5.8%
  • cardiac neuron CL0010022
    CSI -10.7
    rCSI -34.1%
    PRS 2.3%
  • retinal bipolar neuron CL0000748
    CSI -9.1
    rCSI -17.1%
    PRS 2.5%
  • fibroblast of cardiac tissue CL0002548
    CSI -7.8
    rCSI -37.2%
    PRS 1.6%
  • renal beta-intercalated cell CL0002201
    CSI -6.9
    rCSI -16.6%
    PRS 4.1%
  • VIP GABAergic cortical interneuron CL4023016
    CSI -6.7
    rCSI -8.0%
    PRS 1.9%
  • neural cell CL0002319
    CSI -6.3
    rCSI -23.8%
    PRS 7.1%
  • dopaminergic neuron CL0000700
    CSI -6.3
    rCSI -35.6%
    PRS 0.9%
  • vascular leptomeningeal cell CL4023051
    CSI -5.9
    rCSI -10.3%
    PRS 2.5%
  • endocardial cell CL0002350
    CSI -5.9
    rCSI -28.1%
    PRS 5.5%
  • epithelial cell of proximal tubule CL0002306
    CSI -5.3
    rCSI -12.9%
    PRS 3.3%
  • Schwann cell CL0002573
    CSI -5.1
    rCSI -14.6%
    PRS 4.3%
  • naive T cell CL0000898
    CSI -4.9
    rCSI -3.4%
    PRS 4.5%
  • platelet CL0000233
    CSI -4.2
    rCSI -17.2%
    PRS 9.7%
  • tracheobronchial smooth muscle cell CL0019019
    CSI -3.9
    rCSI -6.9%
    PRS 4.2%
  • lung pericyte CL0009089
    CSI -3.5
    rCSI -9.3%
    PRS 3.7%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI -3.5
    rCSI -6.2%
    PRS 1.9%
  • adipocyte CL0000136
    CSI -3.4
    rCSI -4.4%
    PRS 4.1%
  • lung interstitial macrophage CL4033043
    CSI -2.6
    rCSI -5.9%
    PRS 8.1%
  • subcutaneous adipocyte CL0002521
    CSI -2.5
    rCSI -12.8%
    PRS 1.9%
  • renal interstitial pericyte CL1001318
    CSI -2.5
    rCSI -6.8%
    PRS 3.6%
  • pulmonary capillary endothelial cell CL4028001
    CSI -2.4
    rCSI -4.5%
    PRS 5.0%
  • regular ventricular cardiac myocyte CL0002131
    CSI -2.3
    rCSI -14.5%
    PRS 2.6%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI -2.3
    rCSI -2.9%
    PRS 1.8%
  • pulmonary alveolar type 1 cell CL0002062
    CSI -2.0
    rCSI -11.6%
    PRS 4.8%
  • stratified epithelial cell CL0000079
    CSI -1.9
    rCSI -11.9%
    PRS 16.5%
  • astrocyte of the cerebral cortex CL0002605
    CSI -1.5
    rCSI -3.3%
    PRS 2.0%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI -1.4
    rCSI -3.6%
    PRS 3.8%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI -1.4
    rCSI -3.9%
    PRS 4.5%
  • cord blood hematopoietic stem cell CL2000095
    CSI -1.3
    rCSI -25.2%
    PRS 26.9%
  • immature innate lymphoid cell CL0001082
    CSI -1.3
    rCSI -39.6%
    PRS 50.8%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI -1.1
    rCSI -1.1%
    PRS 5.0%
  • periportal region hepatocyte CL0019026
    CSI -1.1
    rCSI -4.1%
    PRS 5.4%
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI -1.0
    rCSI -2.1%
    PRS 1.3%
  • hepatic pit cell CL2000054
    CSI -0.6
    rCSI -7.6%
    PRS 35.9%
  • mucus secreting cell CL0000319
    CSI -0.5
    rCSI -0.8%
    PRS 4.1%
  • Purkinje cell CL0000121
    CSI -0.5
    rCSI -6.1%
    PRS 27.4%
  • epicardial adipocyte CL1000309
    CSI -0.4
    rCSI -1.4%
    PRS 5.4%
  • pericyte CL0000669
    CSI -0.4
    rCSI -1.0%
    PRS 24.8%
  • cytotoxic T cell CL0000910
    CSI -0.3
    rCSI -1.8%
    PRS 5.0%
  • primordial germ cell CL0000670
    CSI -0.3
    rCSI -1.4%
    PRS 24.4%
  • medium spiny neuron CL1001474
    CSI 0.1
    rCSI 0.6%
    PRS 0.3%
  • parietal epithelial cell CL1000452
    CSI 0.1
    rCSI 0.2%
    PRS 3.2%
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 0.1
    rCSI 0.3%
    PRS 1.7%
  • B-1 B cell CL0000819
    CSI 0.2
    rCSI 3.8%
    PRS 19.1%
  • mesangial cell CL0000650
    CSI 0.2
    rCSI 0.9%
    PRS 5.9%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.3
    rCSI 0.9%
    PRS 14.7%
  • NKp44-negative group 3 innate lymphoid cell, human CL0001080
    CSI 0.3
    rCSI 9.2%
    PRS 41.1%
  • Kupffer cell CL0000091
    CSI 0.3
    rCSI 0.7%
    PRS 3.0%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 0.3
    rCSI 1.9%
    PRS 12.7%
  • IgM plasma cell CL0000986
    CSI 0.4
    rCSI 1.6%
    PRS 17.3%
  • collagen secreting cell CL0000667
    CSI 0.4
    rCSI 2.1%
    PRS 18.6%
  • double negative T regulatory cell CL0011024
    CSI 0.4
    rCSI 7.1%
    PRS 28.1%
  • sst GABAergic cortical interneuron CL4023017
    CSI 0.4
    rCSI 0.5%
    PRS 2.1%
  • smooth muscle cell of the pulmonary artery CL0002591
    CSI 0.4
    rCSI 3.4%
    PRS 18.5%
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 0.5
    rCSI 5.0%
    PRS 5.5%
  • S cone cell CL0003050
    CSI 0.5
    rCSI 2.2%
    PRS 3.0%
  • decidual natural killer cell, human CL0002343
    CSI 0.5
    rCSI 5.2%
    PRS 30.0%
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 0.5
    rCSI 1.0%
    PRS 3.3%
  • ependymal cell CL0000065
    CSI 0.6
    rCSI 1.2%
    PRS 1.1%
  • enteroglial cell CL4040002
    CSI 0.7
    rCSI 3.7%
    PRS 8.0%
  • follicular B cell CL0000843
    CSI 0.8
    rCSI 2.8%
    PRS 16.3%
  • diffuse bipolar 3a cell CL4033029
    CSI 0.8
    rCSI 5.2%
    PRS 6.4%
  • odontoblast CL0000060
    CSI 0.8
    rCSI 17.5%
    PRS 18.7%
  • smooth muscle cell of prostate CL1000487
    CSI 0.9
    rCSI 5.1%
    PRS 18.0%
  • macroglial cell CL0000126
    CSI 0.9
    rCSI 2.3%
    PRS 5.8%
  • podocyte CL0000653
    CSI 0.9
    rCSI 4.0%
    PRS 3.2%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 1.0
    rCSI 2.3%
    PRS 23.0%
  • tissue-resident macrophage CL0000864
    CSI 1.0
    rCSI 4.6%
    PRS 8.9%
  • glycinergic amacrine cell CL4030028
    CSI 1.0
    rCSI 2.5%
    PRS 4.6%
  • fast muscle cell CL0000190
    CSI 1.0
    rCSI 4.0%
    PRS 15.1%
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 1.0
    rCSI 3.4%
    PRS 1.5%
  • uterine smooth muscle cell CL0002601
    CSI 1.2
    rCSI 7.6%
    PRS 24.8%
  • ON parasol ganglion cell CL4033052
    CSI 1.2
    rCSI 16.5%
    PRS 2.5%
  • eye photoreceptor cell CL0000287
    CSI 1.2
    rCSI 13.2%
    PRS 12.0%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.3
    rCSI 3.3%
    PRS 11.6%
  • cardiac muscle cell CL0000746
    CSI 1.3
    rCSI 1.9%
    PRS 2.7%
  • regular atrial cardiac myocyte CL0002129
    CSI 1.3
    rCSI 4.2%
    PRS 3.9%
  • inflammatory macrophage CL0000863
    CSI 1.3
    rCSI 2.2%
    PRS 6.5%
  • neuroplacodal cell CL0000032
    CSI 1.4
    rCSI 12.7%
    PRS 12.4%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 1.4
    rCSI 14.9%
    PRS 15.9%
  • endocrine cell CL0000163
    CSI 1.4
    rCSI 7.1%
    PRS 15.2%
  • cerebral cortex neuron CL0010012
    CSI 1.4
    rCSI 5.7%
    PRS 4.0%
  • B-2 B cell CL0000822
    CSI 1.5
    rCSI 30.9%
    PRS 20.4%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.5
    rCSI 12.3%
    PRS 3.3%
  • retinal rod cell CL0000604
    CSI 1.5
    rCSI 2.7%
    PRS 3.5%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.6
    rCSI 2.7%
    PRS 2.4%
  • inhibitory interneuron CL0000498
    CSI 1.6
    rCSI 3.7%
    PRS 3.0%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 1.6
    rCSI 4.1%
    PRS 2.5%
  • airway submucosal gland duct basal cell CL4033024
    CSI 1.7
    rCSI 11.1%
    PRS 15.6%
  • cardiac endothelial cell CL0010008
    CSI 1.8
    rCSI 7.1%
    PRS 3.6%
  • brush cell CL0002204
    CSI 1.8
    rCSI 3.5%
    PRS 9.2%
  • indirect pathway medium spiny neuron CL4023029
    CSI 1.8
    rCSI 43.1%
    PRS 2.0%
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 1.8
    rCSI 2.9%
    PRS 8.1%
  • Merkel cell CL0000242
    CSI 1.8
    rCSI 42.9%
    PRS 23.6%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 1.8
    rCSI 10.3%
    PRS 12.1%
  • cell of skeletal muscle CL0000188
    CSI 1.9
    rCSI 20.4%
    PRS 22.8%
  • central nervous system neuron CL2000029
    CSI 1.9
    rCSI 14.1%
    PRS 1.4%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Heterogeneous nuclear ribonucleoprotein A3, encoded by the [HNRNPA3](/details-gene/220988) gene, is an RNA-binding protein primarily involved in the post-transcriptional regulation of gene expression. Its main functions are centered on mRNA processing, particularly pre-mRNA splicing within the nucleus. **Overall**, expression data reveals that [HNRNPA3](/details-gene/220988) is most significantly expressed in progenitor and stem cell populations, most notably [hematopoietic stem cell](/details-cell/CL0000037)s and other myeloid and lymphoid progenitors. This expression pattern, combined with its role in the spliceosome, suggests that [HNRNPA3](/details-gene/220988) plays a fundamental role in regulating the complex gene expression programs that govern cell fate decisions, proliferation, and differentiation. ## Cellular Roles and Expression Landscape The expression profile of [HNRNPA3](/details-gene/220988) strongly points to a crucial function in hematopoiesis and the maintenance of cellular immaturity. Its highest significance scores are found in [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 119.20), [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 98.43), [common myeloid progenitor](/details-cell/CL0000049) (CSI: 97.55), and [pro-B cell](/details-cell/CL0000826) (CSI: 88.47). High expression is also observed in other highly proliferative or metabolically active cell types, such as [plasmablast](/details-cell/CL0000980)s, [keratinocyte](/details-cell/CL0000312)s, and various epithelial cells, which are characterized by extensive protein synthesis and transcriptional activity. Conversely, [HNRNPA3](/details-gene/220988) shows low to negative significance in many terminally differentiated cell types. This is particularly evident in the nervous system, with low scores in [cardiac neuron](/details-cell/CL0010022), [retinal bipolar neuron](/details-cell/CL0000748), and [Schwann cell](/details-cell/CL0002573). Similarly, its low significance in mature lymphoid populations like [alpha-beta T cell](/details-cell/CL0000789)s and [naive T cell](/details-cell/CL0000898)s contrasts sharply with its high expression in their progenitors. This dichotomy suggests that [HNRNPA3](/details-gene/220988) expression is tightly regulated during cellular differentiation, with its activity being essential for progenitor states and subsequently downregulated upon terminal commitment. ## Pathways and Molecular Function Functionally, [HNRNPA3](/details-gene/220988) is a core component of RNA metabolism machinery. Gene Ontology annotations confirm its localization to the [Nucleus](/details-cell/GO:0005634) and [Nucleoplasm](/details-cell/GO:0005654), where it participates in [Ribonucleoprotein complex](/details-cell/GO:1990904)es. Its molecular functions are dominated by [Rna binding](/details-cell/GO:0003723), including specific [Mrna 3'-utr binding](/details-cell/GO:0003730), and [Protein binding](/details-cell/GO:0005515), which are essential for its role in the spliceosome. It is a known component of the [Catalytic step 2 spliceosome](/details-cell/GO:0071013) and is integral to the biological process of [Mrna splicing, via spliceosome](/details-cell/GO:0000398). These functions are further contextualized by Reactome pathway analysis, which places [HNRNPA3](/details-gene/220988) in the overarching [Metabolism of rna](/details-pathway/R-HSA-8953854) pathway, as well as the more specific [Mrna splicing](/details-pathway/R-HSA-72172) and [Processing of capped intron-containing pre-mrna](/details-pathway/R-HSA-72203) pathways. This molecular role is consistent with its cellular expression pattern; the extensive alternative splicing required to orchestrate differentiation in hematopoietic progenitors and the high demand for mRNA processing in antibody-producing [plasmablast](/details-cell/CL0000980)s align perfectly with the core functions of [HNRNPA3](/details-gene/220988). Early research identified it as an RNA trafficking response element-binding protein, reinforcing its role in post-transcriptional control ([Link](https://doi.org/10.1074/jbc.m200050200)). ## Research Directions The data strongly suggest that [HNRNPA3](/details-gene/220988) is a pivotal regulator of cell fate, particularly within the hematopoietic system. Its high expression in stem and progenitor cells, coupled with its downregulation in differentiated lineages, positions it as a key node in the control of differentiation programs. Based on these observations, several testable hypotheses can be proposed: 1. **[HNRNPA3](/details-gene/220988) is essential for maintaining hematopoietic stem cell (HSC) self-renewal, and its forced downregulation is sufficient to trigger premature differentiation.** Its high expression in HSCs suggests it may regulate the splicing of transcripts critical for quiescence or multipotency. 2. **During lymphopoiesis and myelopoiesis, [HNRNPA3](/details-gene/220988) controls lineage commitment by directing the alternative splicing of key transcription factors.** For example, it might regulate the isoforms of master regulators like GATA1 or PU.1, tipping the balance between different myeloid or erythroid fates. 3. **Aberrant expression or somatic mutation of [HNRNPA3](/details-gene/220988) may contribute to hematological malignancies, such as myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML), by disrupting normal splicing patterns and locking cells in an undifferentiated, proliferative state.** To test the second hypothesis regarding its role in lineage commitment via alternative splicing, a key experiment could be designed. **One could perform CRISPR-Cas9-mediated knockout of [HNRNPA3](/details-gene/220988) in primary human CD34+ hematopoietic stem and progenitor cells.** These modified cells, alongside wild-type controls, would then be cultured under conditions that promote differentiation towards either the myeloid or erythroid lineage. At multiple time points, cells would be harvested for deep RNA-sequencing. Computational analysis would focus on identifying differential transcript usage and alternative splicing events between the knockout and control cells, thereby revealing the direct splicing targets of [HNRNPA3](/details-gene/220988) and how their mis-splicing perturbs normal hematopoietic differentiation. From a therapeutic perspective, [HNRNPA3](/details-gene/220988) presents a potential target for **inhibition**. As an intracellular RNA-binding protein, it is not amenable to antibody-based therapies but could be targeted by small molecule inhibitors designed to interfere with its RNA-binding pocket or its interactions with other spliceosome components. Given its potential role in maintaining an undifferentiated state, such an inhibitor could be explored as a differentiation-inducing therapy in cancers like AML, where malignant cells are arrested in a progenitor-like state. However, its high expression in normal progenitor populations raises significant concerns about on-target toxicity, suggesting that therapeutic application would likely require highly targeted drug delivery systems or be limited to contexts where the therapeutic window is favorable.

Genular Protein ID: 263495746

Symbol: ROA3_HUMAN

Name: Heterogeneous nuclear ribonucleoprotein A3

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11886857

Title: Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein.

PubMed ID: 11886857

DOI: 10.1074/jbc.m200050200

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 11991638

Title: Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

PubMed ID: 11991638

DOI: 10.1017/s1355838202021088

PubMed ID: 14654843

Title: Proteomic characterization of the human centrosome by protein correlation profiling.

PubMed ID: 14654843

DOI: 10.1038/nature02166

PubMed ID: 16964243

Title: A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

PubMed ID: 16964243

DOI: 10.1038/nbt1240

PubMed ID: 17487921

Title: Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.

PubMed ID: 17487921

DOI: 10.1002/elps.200600782

PubMed ID: 18220336

Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.

PubMed ID: 18220336

DOI: 10.1021/pr0705441

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 24129315

Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

PubMed ID: 24129315

DOI: 10.1074/mcp.o113.027870

PubMed ID: 25218447

Title: Uncovering global SUMOylation signaling networks in a site-specific manner.

PubMed ID: 25218447

DOI: 10.1038/nsmb.2890

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

Sequence Information:

  • Length: 378
  • Mass: 39595
  • Checksum: 832372C4C29547B1
  • Sequence:
  • MEVKPPPGRP QPDSGRRRRR RGEEGHDPKE PEQLRKLFIG GLSFETTDDS LREHFEKWGT 
    LTDCVVMRDP QTKRSRGFGF VTYSCVEEVD AAMCARPHKV DGRVVEPKRA VSREDSVKPG 
    AHLTVKKIFV GGIKEDTEEY NLRDYFEKYG KIETIEVMED RQSGKKRGFA FVTFDDHDTV 
    DKIVVQKYHT INGHNCEVKK ALSKQEMQSA GSQRGRGGGS GNFMGRGGNF GGGGGNFGRG 
    GNFGGRGGYG GGGGGSRGSY GGGDGGYNGF GGDGGNYGGG PGYSSRGGYG GGGPGYGNQG 
    GGYGGGGGYD GYNEGGNFGG GNYGGGGNYN DFGNYSGQQQ SNYGPMKGGS FGGRSSGSPY 
    GGGYGSGGGS GGYGSRRF

Genular Protein ID: 2084854245

Symbol: A0A7I2V2R3_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 15815621

Title: Generation and annotation of the DNA sequences of human chromosomes 2 and 4.

PubMed ID: 15815621

DOI: 10.1038/nature03466

Sequence Information:

  • Length: 331
  • Mass: 35412
  • Checksum: 4F643F1316F299CE
  • Sequence:
  • MEVKPPPGRP QPDSGRRRRR RGEEGHDPKE PEQLRKLFIG GLSFETTDDS LREHFEKWGT 
    LTDCVVMRDP QTKRSRGFGF VTYSCVEEVD AAMCARPHKV DGRVVEPKRA VSREDSVKPG 
    AHLTVKKIFV GGIKEDTEEY NLRDYFEKYG KIETIEVMED RQSGKKRGFA FVTFDDHDTV 
    DKIVVQKYHT INGHNCEVKK ALSKQEMQSA GSQRGRGGGS GNFMGRGGNF GGGGGNFGRG 
    GNFGGRGGYG GGGGGSRGSY GGGDGGYNGF GGDGNYGGGG NYNDFGNYSG QQQSNYGPMK 
    GGSFGGRSSG SPYGGGYGSG GGSGGYGSRR F

Genular Protein ID: 412534365

Symbol: B4DDB6_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11181995

Title: The sequence of the human genome.

PubMed ID: 11181995

DOI: 10.1126/science.1058040

Sequence Information:

  • Length: 356
  • Mass: 37029
  • Checksum: C2D8451FC6D6A60A
  • Sequence:
  • MEGHDPKEPE QLRKLFIGGL SFETTDDSLR EHFEKWGTLT DCVVMRDPQT KRSRGFGFVT 
    YSCVEEVDAA MCARPHKVDG RVVEPKRAVS REDSVKPGAH LTVKKIFVGG IKEDTEEYNL 
    RDYFEKYGKI ETIEVMEDRQ SGKKRGFAFV TFDDHDTVDK IVVQKYHTIN GHNCEVKKAL 
    SKQEMQSAGS QRGRGGGSGN FMGRGGNFGG GGGNFGRGGN FGGRGGYGGG GGGSRGSYGG 
    GDGGYNGFGG DGGNYGGGPG YSSRGGYGGG GPGYGNQGGG YGGGGGYDGY NEGGNFGGGN 
    YGGGGNYNDF GNYSGQQQSN YGPMKGGSFG GRSSGSPYGG GYGSGGGSGG YGSRRF